
|Articles|April 30, 2003
Testosterone levels correlate with pathologic stage of prostate cancer
Chicago-Pretreatment testosterone levels correlate with pathologic stagesof prostate cancer and may serve as an independent predictor of extraprostaticdisease in patients initially diagnosed with localized cancers, accordingto a study from the Center for Prostatic Disease Research in Rockville,MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











